Finally, the expanded indication landscape suggests that the GLP-1 platform will increasingly compete not just within obesity, but across MASH, cardiovascular protection, and potentially other metabolic conditions
Materials Res., online pub
Regulatory and Safety Context Since discontinuation, AOD-9604 has remained unapproved by major regulators such as the US FDA , EMA , and TGA
One significant limitation is the use of a diet diluted with indigestible cellulose (DL)
Safe When Supervised: Delivered with professional medical oversight, including screening and follow-up to ensure patient safety and eligibility
But if you are considering having them treated, then here is everything you need to know